ClinicalTrials.Veeva

Menu

Study of ADAMTS-13 Activity, Von Willebrand Factor and Platelet-Monocyte Aggregation in Coronary Artery Disease (ADVANCE-PCI)

U

University College Cork (UCC)

Status

Terminated

Conditions

Coronary Artery Disease

Treatments

Other: Blood draws

Study type

Observational

Funder types

Other

Identifiers

NCT00905294
INFACTs 2009-001

Details and patient eligibility

About

The purpose of this research is to determine the relationship between proteins and enzymes in the blood and how they work with platelets to form blood clots in patients with coronary artery disease. The investigators hypothesize that the relationship between these factors could potentially be useful in identifying patients at higher risk for heart attacks.

Enrollment

11 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admission to hospital with suspected index event of Non-ST-Elevation Myocardial Infarction (NSTEMI), Unstable Angina (UA) or Stable Angina (SA)
  • Planned percutaneous coronary intervention during admission

Exclusion criteria

  • Recent history (< 6 months) of an acute coronary syndrome (other than current admission) or stroke
  • Recent history (< 6 months) of major surgery, trauma or thromboembolic event
  • Percutaneous coronary or peripheral intervention or any stent placement performed within the past 6 months
  • Current evidence of infection

Trial design

11 participants in 1 patient group

coronary artery disease
Description:
Subjects with coronary artery disease undergoing percutaneous coronary intervention
Treatment:
Other: Blood draws

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems